DEA's revised and updated drug fact sheet about vaping and marijuana concentrates - what are they, what their origin is, what are the common street names for vaping and marijuana concentrates, what do vapes and various concentrates look like, how they are used/abused, what their effect of their use on...

DEA's revised and updated drug fact sheet about the class of drugs known as benzodiazepines (tranquilizers) - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and...

This document is an internal Drug Enforcement Administration quality system document for latent print examination. The effective period of the document is May 4, 2020 to August 18, 2022 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the...

Drugs of Abuse delivers clear, scientific information about drugs in a factual, straightforward way. With the information in this guide, parents and caregivers can help their children make smart choices and avoid the consequences of drug abuse. This publication covers topics including the Controlled Substances Act and introduces drug classes...

The Drug Enforcement Administration is adjusting the 2020 aggregate production quotas for certain controlled substances in schedule II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine and pseudoephedrine. This increase is in response to the current nationwide COVID-19 public health emergency...

The flow of fentanyl into the United States in 2019 is more diverse compared to the start of the fentanyl crisis in 2014, with new source countries and new transit countries emerging as significant trafficking nodes. This is exacerbating the already multi-faceted fentanyl crisis by introducing additional source countries into...

Statement of Thomas Prevoznik Deputy Assistant Administrator Diversion Control Division Drug Enforcement Administration U.S. Department of Justice Before the Subcommittee on Health House Committee on Energy and Commerce U.S. House of Representatives at a hearing entitled “Combatting an epidemic: legislation to help patients with substance use disorders” presented March 3...

The DEA New Orleans Division conducted a five-year review of the data on synthetic substances reported in the National Forensic Laboratory Information System for their area of responsibility. The findings revealed that Louisiana submitted the majority of reports for synthetic cannabinoid substance and synthetic cathinones substance for 2013 to 2017...

DEA Acting Administrator Uttam Dhillon announces Operation Crystal Shield in response to a dramatic increase in methamphetamine trafficking through eight major cities in the U.S. The press conference took place at the DEA Field Division Headquarters in Atlanta, Georgia on February 20, 2020.

The 2019 National Drug Threat Assessment (NDTA) is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of both licit and illicit drugs. The report combines federal, state, local, and tribal law enforcement reporting; public health data; open...